4//SEC Filing
ROME JERALD K 4
Accession 0000914062-13-000107
CIK 0001133416other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 5:22 PM ET
Size
7.9 KB
Accession
0000914062-13-000107
Insider Transaction Report
Form 4
ROME JERALD K
Director
Transactions
- Exercise/Conversion
Common Stock
2013-03-07$2.28/sh+2,500$5,700→ 22,058 total - Exercise/Conversion
Employee Stock Option (right to buy)
2013-03-07−2,500→ 0 totalExercise: $2.28From: 2008-03-13Exp: 2013-03-13→ Common Stock (2,500 underlying)
Holdings
- 7,002(indirect: By Children)
Common Stock
Footnotes (2)
- [F1]The Company effected a 1-for-6 reverse stock split in March 2012, resulting in a corresponding reduction in the number of shares of common stock owned by the reporting person.
- [F2]This option was previously reported as covering 15,000 shares at an exercise price of $0.38 per share, but was adjusted to reflect the 1-for-6 reverse stock split that occurred in March 2012.
Documents
Issuer
GALECTIN THERAPEUTICS INC
CIK 0001133416
Entity typeother
Related Parties
1- filerCIK 0001285677
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 5:22 PM ET
- Size
- 7.9 KB